Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-306-6 | CAS number: 57-00-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Meets generally accepted scientific standards, well documented and acceptable for assessment. Justification for read-across: When dissolved in water there is no chemical difference between creatine monohydrate and creatine. The crystal water contained in creatine monohydrate does not account for the toxicity profile of the compound. However, it has to be considered that the results obtained with creatine monohydrate have to be converted to the respective creatine concentration as creatine has a lower molecular weight (131.1332 g/mol) compared to creatine monohydrate (149.1484 g/mol). 100 mg creatine monohydrate per liter correspond to approx. 88 mg creatine per liter.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Long-term creatine supplementation does not significantly affect clinical markers of health in athletes
- Author:
- Kreider, R.B.; Melton, C.; Rasmussen,C.J.; Greenwood, M.; Lancaster, S.; Cantler, E.C.; Milnor, P.; Almada, A.L.
- Year:
- 2 003
- Bibliographic source:
- Molecular and Cellular Biochemistry 244: 95–104, 2003
Materials and methods
- Type of study / information:
- Publication: The result of a cohort study with 98 football players that were administered in an open label manner creatine or non-creatine containing supplements following training sessions over a 21-month period are reported. The long-term safety of creatine supplementation was elucidated by quantitative clinical chemistry and analysis of urine samples.
- Endpoint addressed:
- repeated dose toxicity: oral
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Cohort study: This study examined the effects of long-term creatine supplementation on a 69-item panel of serum, whole blood, and urinary markers of clinical health status in athletes. Over a 21-month period, 98 Division IA college football players were administered in an open label manner creatine or non-creatine containing supplements following training sessions.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- N-(aminoiminomethyl)-N-methyl-Glycine, monohydrate
- Cas Number:
- 6020-87-7
- Molecular formula:
- C4H9N3O2*H2O
- IUPAC Name:
- N-(aminoiminomethyl)-N-methyl-Glycine, monohydrate
- Details on test material:
- - Name of test material (as cited in study report): Creatine monohydrate
Constituent 1
Method
- Ethical approval:
- not specified
- Remarks:
- The individuals volunteered to participate in the study
- Details on study design:
- One hundred and sixteen National Collegiate Athletic Association (NCAA) Division IA college football players (subjects were 19.2 ± 2 years (range 18–23 years), 185 ± 8 cm (range 173–191 cm), 101 ± 18 kg (range 70–148 kg)) volunteered to participate in this study over a 2 year period. Approximately 65 subjects volunteered to participate during the first year and about 40 subjects volunteered to participate in the second year of the study. Of these, 98 subjects donated pre and at least one subsequent blood and urine sample during the course of the study.
Subjects who chose to take creatine were administered in an open label manner 15.75 g/day of creatine monohydrate for 5 days and an average of 5 g/day thereafter in 5–10 g doses following supervised training sessions. Supplement intake was monitored and recorded in order to document creatine intake.
Training duration, type, and general intensity as well as environmental conditions were recorded. Training averaged of 118 ± 68 min per session with an average intensity of 3.3 ± 1 on a 1–5 scale where 1 was equivalent to a walk-through practice prior to games and 5 was equivalent to game competition. Environmental conditions during training and competition ranged from 8–37°C (mean 24.2 ± 8°C) and 20–98% relative humidity (52.2 ± 16%).
Fasting blood and 24-h urine samples were collected on as many athletes willing to provide samples at 0, 1, 1.5, 4, 6, 10, 12, 17, and 21 months of training (typically 30–55 per testing session).
Subjects observed an overnight 8-h fast prior to donating blood samples.
Standard clinical analysis (SmithKline Beecham Clinical Laboratories; Ann Arbor, MI, USA) and a complete metabolic clinical chemistry panel (Olympus AU5200 automated chemistry analyzer; Melville, NY, USA) were run. Cell blood counts with percent differentials and platelet determination were run on whole blood samples using a Coulter STKS automated analyzer using standard procedures (Coulter Inc., Hialeah, FL, USA).
Urine samples were collected in 24-h collection containers according to standard procedures. A 15-item urinalysis was performed using the Clinitek Atlas ® automated urine chemistry analyzer (Bayer Diagnostics, Tarrytown, NY, USA). Furthermore the plasma creatinine, urine creatinine, and
creatinine clearance using high performance liquid chromatography (HPLC) were determined. - Exposure assessment:
- measured
- Details on exposure:
- TYPE OF EXPOSURE: orally: Creatine monohydrate was added to sport drinks or carbohydrate/protein drinks that were offered to the players following training sessions, practices, and games by research assistants working with the strength and conditioning staff
TYPE OF EXPOSURE MEASUREMENT: Personal sampling/ Biomonitoring (urine) / Biomonitoring blood: Fasting blood and 24-h urine samples were collected at 0, 1, 1.5, 4, 6, 10, 12, 17, and 21 months of training
EXPOSURE LEVELS:
EXPOSURE PERIOD: 21 month period
POSTEXPOSURE PERIOD:
DESCRIPTION / DELINEATION OF EXPOSURE GROUPS / CATEGORIES:
Results and discussion
- Results:
- No significant differences (p = 0.51) between creatine users and non-users in the quantitative panel of blood and urine markers assessed.No significant differences (p > 0.05) were observed among groups in any of the quantitative markers analyzed with the exception that significant interactions were observed
in sodium, chloride, and hematocrit which were not of physiological or clinical relevance. No apparent differences were observed among groups in the qualitative urinary assessment of color, appearance, glucose, bilirubin, ketones, hemoglobin, total protein, nitrates, leukocyte esterase, white blood cells, red blood cells, epithelial cells, bacteria, amorphic cyrstals, or calcium oxalate.
Applicant's summary and conclusion
- Conclusions:
- The results of this study show that long-term creatine supplementation (up to 21-months) does not appear to adversely effect markers of health status in athletes undergoing intense training in comparison to athletes who do not take creatine.
- Executive summary:
Results of the present study indicate that short and long-term creatine supplementation (up to 21 months) does not appear to adversely affect clinical markers of health status in a large number of athletes undergoing intense training in comparison to athletes who do not take creatine.
Results of the present study showed that no significant differences were observed among creatine and non-creatine users in serum creatinine, urinary creatinine excretion, or creatinine clearance.
Concerns that creatine intake increases muscle and/or liver damage could not be verified in this study. Higher levels of muscle/and or liver enzymes (i.e. creatine kinase, CK) are reported for athletes in comparison to untrained individuals. In this study no significant differences were observed among creatine and non-creatine users in CK values and lactate dehydrogenase (LDH), aspartate aminotransferase (AST), or alanine aminotransferase (ALT) values.
Therefore, Creatine monohydrate is not considered to adversely affect the renal function or increase muscle and/or liver damage in individuals.
Justification for read-across:
When dissolved in water there is no chemical difference between creatine monohydrate and creatine. The crystal water contained in creatine monohydrate does not account for the toxicity profile of the compound. However, it has to be considered that the results obtained with creatine monohydrate have to be converted to the respective creatine concentration as creatine has a lower molecular weight (131.1332 g/mol) compared to creatine monohydrate (149.1484 g/mol). 100 mg creatine monohydrate per liter correspond to approx. 88 mg creatine per liter.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.